NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 168 filers reported holding NOVOCURE LTD in Q4 2018. The put-call ratio across all filers is 0.16 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $358,000 | +67.3% | 1,612 | 0.0% | 0.00% | +100.0% |
| Q1 2021 | $214,000 | -85.4% | 1,612 | -81.0% | 0.00% | -88.9% |
| Q4 2020 | $1,464,000 | +59.3% | 8,462 | +2.6% | 0.02% | +50.0% |
| Q3 2020 | $919,000 | -72.4% | 8,250 | -85.3% | 0.01% | -73.9% |
| Q2 2020 | $3,331,000 | -12.1% | 56,160 | -0.2% | 0.05% | -23.3% |
| Q1 2020 | $3,790,000 | -12.0% | 56,270 | +0.5% | 0.06% | +39.5% |
| Q4 2019 | $4,305,000 | +1.7% | 56,010 | -1.0% | 0.04% | -6.5% |
| Q3 2019 | $4,233,000 | +48.4% | 56,600 | +25.5% | 0.05% | +48.4% |
| Q2 2019 | $2,852,000 | +31.2% | 45,100 | 0.0% | 0.03% | +29.2% |
| Q1 2019 | $2,173,000 | +3004.3% | 45,100 | +2047.6% | 0.02% | +2300.0% |
| Q4 2018 | $70,000 | – | 2,100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Invus Financial Advisors, LLC | 350,884 | $77,833,000 | 15.51% |
| HARTLINE INVESTMENT CORP/ | 302,194 | $67,033,000 | 8.47% |
| Darsana Capital Partners LP | 700,000 | $155,274,000 | 4.42% |
| MORGAN JESS S & CO INC | 23,775 | $5,274,000 | 3.47% |
| Soleus Capital Management, L.P. | 98,975 | $21,955,000 | 3.38% |
| Montanaro Asset Management Ltd | 116,650 | $25,875,000 | 3.26% |
| Taylor Frigon Capital Management LLC | 31,035 | $6,884,000 | 2.15% |
| Rhenman & Partners Asset Management AB | 120,000 | $26,618,000 | 1.81% |
| COURAGE CAPITAL MANAGEMENT LLC | 10,000 | $2,218,000 | 1.33% |
| Derbend Asset Management | 5,789 | $1,284,000 | 1.20% |